ARTICLE SUMMARY:
Five CEOs discuss their companies’ application of AI in medtech to address complex problems in pathology, neurology, cardiology, and clinical research and development.
Artificial intelligence technologies have been part of medtech since the 1990s, but the pace of AI innovation has accelerated in recent years, creating whole new categories of medtech along with a variety of new challenges for health systems and regulators.
At the recent MedTech Strategist Innovation Summit in Dublin, a panel of five CEOs discussed the evolving role of AI in healthcare, including innovation, regulation, and market dynamics, while offering advice on how to advance a differentiated AI solution in an increasingly crowded market.
